Close Menu

Fluxion

NEW YORK (GenomeWeb News) – Fluxion Biosciences today said that it has signed a reagent supply and collaboration agreement with Rubicon Genomics aimed at circulating tumor cell applications.

NEW YORK (GenomeWeb News) – Transgenomic said in a document filed with the US Securities and Exchange Commission this week that its shareholders have approved an increase in the number of authorized shares of the firm's common stock from 100 million to 150 million.

Cellectricon has resumed an IP infringement suit it initially filed against Fluxion last summer.

The cell-analysis toolmaker inked agreements with distributors in Korea and Japan, and sold its first instrument in China.

The firm will use the Phase II grant to develop a high-throughput screening system.

The firm will use the funding to develop its microfluidic system for cancer diagnostics.

The Italian company will distribute the BioFlux platform in parts of Europe, the Mediterranean, and in North Africa.

New Products

Premium

Thermo Fisher Scientific, Promega, MatriCal Bioscience, Fluxion Biosciences

Pages

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.